Arsenic trioxide-mediated cytotoxicity in prostate and ovarian carcinoma lines.

dc.contributor.authorUslu, R
dc.contributor.authorSezgin, C
dc.contributor.authorKarabulut, B
dc.contributor.authorSanli, UA
dc.contributor.authorTobu, M
dc.contributor.authorSaydam, G.
dc.contributor.authorBuyukkececi, F
dc.contributor.authorOmay, SB
dc.contributor.authorGoker, E
dc.date.accessioned2019-10-27T18:24:41Z
dc.date.available2019-10-27T18:24:41Z
dc.date.issued1999
dc.departmentEge Üniversitesien_US
dc.identifier.endpage3784Sen_US
dc.identifier.issn1078-0432
dc.identifier.startpage3783Sen_US
dc.identifier.urihttps://hdl.handle.net/11454/36229
dc.identifier.volume5en_US
dc.identifier.wosWOS:000083945700270en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Assoc Cancer Researchen_US
dc.relation.ispartofClinical Cancer Researchen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleArsenic trioxide-mediated cytotoxicity in prostate and ovarian carcinoma lines.en_US
dc.typeConference Objecten_US

Dosyalar